Massive Bio has made its inaugural strategic investment in Rivvi. Read the announcement

2027 Star Ratings

H2261

Blue Cross Blue Shield of Massachusetts

42,236 members

4.5

0.0 vs 2026Above the 4 star line

Ask about H2261

3 free questions today

Medication adherence

Medication Adherence for Diabetes Medications

4 · 1.0 pt to 5★

Medication Adherence for Hypertension (RAS antagonists)

4 · 1.0 pt to 5★

Medication Adherence for Cholesterol (Statins)

4 · 1.0 pt to 5★

All measures

MeasureStarsScore
C27 Complaints about the Health Plan50.07
C17 Plan All-Cause Readmissions3x55%
C28 Members Choosing to Leave the Plan58%
C10 Osteoporosis Management in Women who had a Fracture237%
C16 Improving Bladder Control448%
C06 Monitoring Physical Activity455%
C15 Reducing the Risk of Falling257%
C20 Follow-up after Emergency Department Visit for People with Multiple High-Risk Chronic Conditions367%
C13 Kidney Health Evaluation for Patients with Diabetes472%
C04 Improving or Maintaining Physical Health3x473%

Other plans from this organization

Source: CMS 2027 Part C and D Star Ratings data, released October 8, 2026. Data loaded October 9, 2026.

Try it on your own data today.

Free to start. Most teams are using it the same day.